COCO · The Vita Coco Company, Inc. · Stock research

Current Thesis

Q2 FY26, reported 2026-07-23, delivered on the fundamental side without ambiguity — net sales $216.2M, +28.1% YoY, diluted EPS $0.82 against roughly $0.55 consensus, adjusted EBITDA $67.2M (31% of net sales) versus $29M (17%) a year earlier, and a full-year raise to $790–805M net sales / $154–161M adjusted EBITDA. The prior published condition for a fundamental break — a Q2 net sales figure below ~$185M — did not come close to triggering.

The price leg broke anyway. The 2026-07-12 trailing 52-week high was $79.70; StockStory marked it at $79.23 (May 2026) on 2026-07-23. The current basis carries a 52-week high of $84.02 adjusted ($85.83 unadjusted), which places the high in the days after the print — INFERRED from those two dated marks rather than observed directly. From there the stock closed $62.25 on 2026-08-07, -25.9% below that high, with RSI(14) at 27.5. A beat-and-raise plus a $175M acquisition produced a marginal new high and then two weeks of supply.

Life-cycle label: SATURATED, dated by the 2026-07-23 reaction. Mainstream coverage, an unambiguously good print, and a thin new bid on the other side of it. What is now being priced is not whether the category works but whether 2026 profitability is a run rate or a tariff-refund-flattered peak.

Bullish and bearish views on The Vita Coco Company, Inc.

The model's bull view on The Vita Coco Company, Inc. (COCO), in brief: Q2 FY26 (2026-07-23): net sales $216.2M, +28.1% YoY, with growth in both branded and private-label coconut water. The bear view: The 49% Q2 gross margin is not the run rate. Both cases follow in full.

Bull Case

• Q2 FY26 (2026-07-23): net sales $216.2M, +28.1% YoY, with growth in both branded and private-label coconut water. Volume- and mix-led.
• Diluted EPS $0.82 vs ~$0.55 consensus (~48% surprise); net income $49.5M vs $23.0M in the year-ago quarter.
• FY26 guidance raised to $790–805M net sales and $154–161M adjusted EBITDA (2026-07-23), against the late-April guide of $720–735M / $132–138M. Two dated guides, both raised inside one quarter.
• Balance sheet: $279M cash, no debt at the Q2 close — a quarter-end date that precedes the Copra outflow.
• Buyback is live and expanded: board added $40M to bring total authorization to $105M, with approximately $44M already repurchased through 2026-07-22. The company was a buyer while the stock was near its high.
• Copra, Inc. Acquired 2026-07-22 for $175M — a super-premium Thai Nam Hom coconut water producer, adding both a price tier above the core brand and owned supply.
• Multiple has compressed while earnings rose: trailing P/E 34.35 at the 2026-08-07 close, against the ~49x characterization carried into the July print.
• Published targets sit above spot: Morgan Stanley $68 (2026-07-28), Piper Sandler $74 (2026-07-09), Wells Fargo $85 (2026-05-18) — all struck above the $62.25 close.

Bear Case

• The 49% Q2 gross margin is not the run rate. Tariff refunds contributed roughly 700bps to Q2 gross margin and ~300bps year-to-date, and management's own FY26 guide is ~40%. The headline profitability that drove the July high carries a one-time component management has already guided away from.
• The catalyst came, the catalyst went. The binary flagged in prior coverage landed on 2026-07-23, resolved bullish on every reported line, and the stock is -25.9% from its post-print high three weeks later. Good news absorbed at a new high is distribution behaviour.
• Morgan Stanley stayed Equal-Weight on 2026-07-28, five days after the beat, lifting the target only to $68. The desk closest in time to the print did not upgrade.
• $175M of cash went out the door on 2026-07-22 against a $279M quarter-end balance struck before the close. Integration of a super-premium niche brand is unproven and nothing about its contribution has been quantified in a reported period.
• Private label was part of the growth mix. Category expansion that runs through private label carries structurally lower margin than the branded line and dilutes the pricing-power story the multiple rests on.
• No dated catalyst inside the window. As of 2026-08-07 the Q3 FY26 date had not been announced. A name that just failed from a high with nothing scheduled for roughly eleven weeks drifts on flow.
• Still a single name. No coconut-water peer cluster confirms or contradicts the regime; sympathy reads have to be borrowed from the broader functional-beverage complex.

Setup & Price Structure

• Last close $62.25 (2026-08-07), -2.92% on the day. Market cap $3.65B, trailing P/E 34.35.
• 52-week range $31.92–$85.83 unadjusted; $84.02 high on the adjusted basis. Distance from high: -25.9%. Three-month return -13.1%.
• RSI(14) at 27.5 — below 30, so the decline is extended rather than crowded-long. Oversold on its own resolves nothing; it describes the speed of the move, not its endpoint.
• Price sits below the mid-July estimated 50-day zone of ~$66–68 and well below the ~$72–74 20-EMA area estimated on 2026-07-12. Both moving-average references have rolled from support to overhead.
• The structural floor of the whole re-rate is the late-April Q1 breakaway gap, estimated near $60. That shelf is what separates a violent give-back inside an uptrend from a full round-trip of the post-Q1 move. The 2026-08-07 close is roughly two dollars above it.
• Positioning observables, stated as observables: buyback active into the drawdown ($44M through 2026-07-22, $105M authorized); no equity issuance into strength on the record; no earnings date scheduled; sell-side targets clustered $68–$85 with the nearest-dated one the lowest of the three.

Catalyst Calendar (next 30 days)

• ~2026-10-29 (est.) — Q3 FY26 print. Unconfirmed; this is the first scheduled event that can re-price the name, and it sits well outside the window.
• Ongoing, no fixed date — repurchase activity under the $105M authorization. Disclosure arrives with the Q3 filing, not on a calendar date.

Elapsed catalysts

• Nothing dated falls inside the next 30 days. As of 2026-08-07, the Q3 FY26 reporting date had not been announced by the company. (passed 2d ago)

What Would Change Our Mind

The structure that matters is the late-April Q1 breakaway gap near $60 — the only piece of the re-rate that has not already been surrendered. A weekly close below $60 retraces the entire post-Q1 move and converts a sharp correction into a failed narrative; at that point the July beat-and-raise will have been fully sold and the burden shifts to the Q3 print to rebuild a base from below.

On the fundamental side, the specific datapoint that would confirm the bear reading is Q3 gross margin printing at or under the ~40% full-year guide once the ~700bps tariff-refund benefit is absent, alongside any deceleration in branded Vita Coco Coconut Water relative to private label. Conversely, the case turns constructive again on a weekly reclaim of the mid-$70s with a higher low above $60 in between, or a Q3 print that holds gross margin above the FY guide on clean, non-refund mix. Absent either, the eleven-week gap to the next dated event is the whole problem: there is nothing scheduled that forces a re-rate in either direction, and the tape has been setting lower highs since the print.

Correlation Notes

• CELH remains the closest functional-beverage momentum analog — same pattern of a high-multiple single-brand grower whose multiple travels with category-growth headlines rather than with staples beta.
• Input and freight sensitivity: coconut/copra sourcing is concentrated in Southeast Asia, and the Q2 margin included tariff refunds. Trade-policy headlines on Thai and Philippine agricultural imports read directly into the gross-margin line, and the Copra deal (2026-07-22) increases that geographic concentration.
• No tight domestic peer set. Coconut water has no listed pure-play comparison, so COCO trades as an idiosyncratic small/mid-cap growth name rather than as a member of a group; theme classification for this name has churned repeatedly and should be treated as low-information.
• Small-cap growth beta: with $3.65B market cap and a 34x trailing multiple, drawdowns in high-multiple consumer growth tend to arrive on the same days regardless of company-specific news.